Affiliate Members | Pharmacology & Therapeutics - McGill University

Updated: Fri, 10/11/2024 - 12:00

Campus/building access, classes and work will return to usual conditions, as of Saturday, Oct. 12. See Campus Public Safety website for details.

Accès au campus et aux immeubles, cours et modalités de travail : retour à la normale à compter du samedi 12 octobre. Complément d’information : Direction de la protection et de la prévention.

Name	Organization	Contact
Matthieu Boucher, Ph.D. Psychiatry, Central Nervous System, Women’s Health & Allergy	National Field Manager, Medical Affairs, Neurosciences Otsuka Canada Pharmaceutical Inc. 2250, boul. Alfred-Nobel, bureau 301 Ville Saint-Laurent, Québec H4S 2C9	Email: matthieu.boucher [at] otsuka-ca.com Tel: 514-814-1540 Fax: 514-332-3107 Web: www.otsukacanada.com
Lionel Breton, Ph.D. CILIA Consulting, Cofounder, CEO	CILIA Consulting 20 avenue de Paris 78000 Versailles, FR	Email: btwocg [at] gmail.com Tel: +33 6 63 18 99 38 Fax: +33 6 17 05 15 38
Lorella Garofalo, Ph.D. Head of Regulatory Affairs, Canada	Global Regulatory Affairs, International Pfizer Canada ULC 17300 Autoroute Trans Canada Kirkland, Quebec H9J 2M5	Email: lorella.garofalo [at] pfizer.com Tel: 514-426-7432 Fax: 514-426-6824 Web: www.pfizer.ca \| Facebook of Pfizer Canada \| @PfizerCA
John W. Gillard, Ph.D.	SVP Research and Product Development Kalgene Pharmaceuticals Inc.	Email: John.gillard [at] kalgene.com Tel: 514 887-8632
Joseph Mancini, Ph.D. Head of Biology; Sr Director at adMare BioInnovations Diabetes/Inflammation	adMare's Innovation Centre 7171 Frederick-Banting Montreal, Quebec H4S 1Z9	Email:joseph.mancini [at] mcgill.ca"> joseph.mancini [at] mcgill.ca Tel: 617-691-7534
Karen Meerovitch, Ph.D Vice-President, Clinical Development Drug/clinical development Ophthalmology	Vice-President, Clinical Development Mimetogen Pharmaceuticals, Inc. 1000 de La Gauchetière St. West Suite 900 Montréal, Québec H3B 5H4	Email: karen.meerovitch [at] mimetogen.com Tel: 514-924-7484
Taylor Cohen, Ph.D Director – Discovery Microbiome Early Vaccines and Immune Therapies	AstraZeneca BioPharmaceuticlas R&D \| Microbial Sciences One Medimmune Way, Gaithersburg, MD 20878	Email: Taylor.cohen [at] astrazeneca.com
Christopher Wright, Ph.D. Chief Development Officer & SVP-Global Development Ironwood Pharmaceuticals Inc	Chief Development Officer & SVP-Global Development Ironwood Pharmaceuticals Inc 100 Summer Street Suite 2300 Boston MA 02110	Email: ciwright1983 [at] comcast.net Web: www.ironwoodpharma.com

Part-Time Affiliate Members - Campus Outaouais

Name	Contact
Dr. Sandra Aubé-Lenglin	sandra.aube-lenglin [at] mcgill.ca
Mrs. Maryam Alrifaee	maryam.alrifaee [at] mcgill.ca
Mrs. Marie Auclair	marie.auclair [at] mcgill.ca
Dr. Tidjani Bichara	tidjani.bichara-idriss [at] mcgill.ca
Dr. Lucie Camarra	lucie.camarra [at] mcgill.ca
Dr. Jocelyne Chrétien	jocelyne.chretien [at] mcgill.ca
Mr. Carl Desparois	carl.desparois [at] mcgill.ca
Mr. Robert Johns	robert.johns [at] mcgill.ca
Mrs. Nathalie Gagnon	nathalie.gagnon5 [at] mcgill.ca
Mrs. Edith Raymond	edith.raymond [at] mcgill.ca
Mrs. Johanne Paradis	johanne.paradis2 [at] mcgill.ca
Mr. Martin Payer	martin.payer [at] mcgill.ca
Mr. Aly Kamel	aly.kamel [at] mcgill.ca

Back to top